Monthly record of Nivolumab's rank (dan/kyu)
month |
dan/kyu |
win/lose |
win ratio |
2024
/04
| 9.00 Kyu |
1 win 2 lose |
.333 |
2024
/03
| 7.00 Kyu |
3 win 1 lose |
.750 |
2024
/02
| 6.00 Kyu |
4 win 4 lose |
.500 |
2024
/01
| 8.00 Kyu |
2 win 2 lose |
.500 |
2023
/11
| 4.00 Kyu |
6 win 9 lose |
.400 |
2023
/10
| 10 Kyu |
0 win 2 lose |
.000 |
2023
/09
| 0.92 Kyu |
10 win 5 lose |
.666 |
2023
/08
| 1.61 Kyu |
17 win 11 lose |
.607 |
2023
/07
| 1.61 Kyu |
13 win 7 lose |
.650 |
2023
/06
| 2.24 Kyu |
18 win 23 lose |
.439 |
2023
/05
| 1.60 Kyu |
22 win 18 lose |
.550 |
2023
/04
| 0.10 Kyu |
12 win 7 lose |
.631 |
©HEROZ, Inc. All Rights Reserved.